TCR Gene Therapy Improves AML Prognosis
- PMID: 31332021
- DOI: 10.1158/2159-8290.CD-NB2019-083
TCR Gene Therapy Improves AML Prognosis
Abstract
T cells engineered to express a receptor specific for Wilms tumor antigen 1 helped prevent relapse in a small trial of patients with acute myeloid leukemia who had received an allogeneic stem-cell transplant.
©2019 American Association for Cancer Research.
Comment on
-
T cell receptor gene therapy targeting WT1 prevents acute myeloid leukemia relapse post-transplant.Nat Med. 2019 Jul;25(7):1064-1072. doi: 10.1038/s41591-019-0472-9. Epub 2019 Jun 24. Nat Med. 2019. PMID: 31235963 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
